These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32075132)

  • 1. Follow the Mutations: Toward Class-Specific, Small-Molecule Reactivation of p53.
    Loh SN
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32075132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancer.
    Blanden AR; Yu X; Loh SN; Levine AJ; Carpizo DR
    Drug Discov Today; 2015 Nov; 20(11):1391-7. PubMed ID: 26205328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc shapes the folding landscape of p53 and establishes a pathway for reactivating structurally diverse cancer mutants.
    Blanden AR; Yu X; Blayney AJ; Demas C; Ha JH; Liu Y; Withers T; Carpizo DR; Loh SN
    Elife; 2020 Dec; 9():. PubMed ID: 33263541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances on mutant p53 research].
    Li DH; Zhang LQ; He FC
    Yi Chuan; 2008 Jun; 30(6):697-703. PubMed ID: 18550490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Prion-like Aggregation of Mutant p53 to Combat Cancer.
    Silva JL; Cino EA; Soares IN; Ferreira VF; A P de Oliveira G
    Acc Chem Res; 2018 Jan; 51(1):181-190. PubMed ID: 29260852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
    Stiewe T; Haran TE
    Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism.
    Yu X; Blanden AR; Narayanan S; Jayakumar L; Lubin D; Augeri D; Kimball SD; Loh SN; Carpizo DR
    Oncotarget; 2014 Oct; 5(19):8879-92. PubMed ID: 25294809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting mutant p53 for efficient cancer therapy.
    Bykov VJN; Eriksson SE; Bianchi J; Wiman KG
    Nat Rev Cancer; 2018 Feb; 18(2):89-102. PubMed ID: 29242642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel cancer therapy by reactivation of the p53 apoptosis pathway.
    Bykov VJ; Wiman KG
    Ann Med; 2003; 35(7):458-65. PubMed ID: 14649328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of mutant p53 by a one-hybrid adaptor protein.
    Roth J; Lenz-Bauer C; Contente A; Löhr K; Koch P; Bernard S; Dobbelstein M
    Cancer Res; 2003 Jul; 63(14):3904-8. PubMed ID: 12873982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of mutant p53: molecular mechanisms and therapeutic potential.
    Selivanova G; Wiman KG
    Oncogene; 2007 Apr; 26(15):2243-54. PubMed ID: 17401433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional Compounds for Activation of the p53-Y220C Mutant in Cancer.
    Miller JJ; Orvain C; Jozi S; Clarke RM; Smith JR; Blanchet A; Gaiddon C; Warren JJ; Storr T
    Chemistry; 2018 Dec; 24(67):17734-17742. PubMed ID: 30230059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relevance of p53 protein and its mutations for novel strategies in cancer therapy].
    Müller P; Nenutil R; Vojtĕsek B
    Cas Lek Cesk; 2004; 143(5):313-7. PubMed ID: 15305766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of p53 protein aggregation as a cancer treatment strategy.
    Kwan K; Castro-Sandoval O; Gaiddon C; Storr T
    Curr Opin Chem Biol; 2023 Feb; 72():102230. PubMed ID: 36436275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule activators of the p53 response.
    Ladds MJGW; Laín S
    J Mol Cell Biol; 2019 Mar; 11(3):245-254. PubMed ID: 30689917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53 reactivation by small molecules makes its way to the clinic.
    Bykov VJ; Wiman KG
    FEBS Lett; 2014 Aug; 588(16):2622-7. PubMed ID: 24768524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 as a hub in cellular redox regulation and therapeutic target in cancer.
    Eriksson SE; Ceder S; Bykov VJN; Wiman KG
    J Mol Cell Biol; 2019 Apr; 11(4):330-341. PubMed ID: 30892598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of p53 protein core domain structural alteration on ovarian cancer survival.
    Rose SL; Robertson AD; Goodheart MJ; Smith BJ; DeYoung BR; Buller RE
    Clin Cancer Res; 2003 Sep; 9(11):4139-44. PubMed ID: 14519637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding p53 functions through p53 antibodies.
    Sabapathy K; Lane DP
    J Mol Cell Biol; 2019 Apr; 11(4):317-329. PubMed ID: 30907951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and Function of p53-DNA Complexes with Inactivation and Rescue Mutations: A Molecular Dynamics Simulation Study.
    Kamaraj B; Bogaerts A
    PLoS One; 2015; 10(8):e0134638. PubMed ID: 26244575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.